Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial

F. K. L. Spijkervet; R. P. E. Pollard; W. H. Abdulahad; M. G. Huitema; A. Visser; J. M. Meijer; J. G. M. Burgerhof; C. G. M. Kallenberg; A. Vissink; F. G. M. Kroese; H. Bootsma

Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial

F. K. L. Spijkervet
, R. P. E. Pollard
, W. H. Abdulahad
, M. G. Huitema
, A. Visser
, J. M. Meijer
, J. G. M. Burgerhof
, C. G. M. Kallenberg
, A. Vissink
, F. G. M. Kroese
, H. Bootsma

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	13-13
Number of pages	1
Journal	Oral diseases
Volume	18
Publication status	Published - Sept-2012

Handle.net

Persistent link

Cite this

Spijkervet, F. K. L., Pollard, R. P. E., Abdulahad, W. H., Huitema, M. G., Visser, A., Meijer, J. M., Burgerhof, J. G. M., Kallenberg, C. G. M., Vissink, A., Kroese, F. G. M., & Bootsma, H. (2012). Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial. Oral diseases, 18, 13-13.

@article{67a87906797646afa418b097ff7c8575,

title = "Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome: data from a placebo-controlled clinical trial",

author = "Spijkervet, \{F. K. L.\} and Pollard, \{R. P. E.\} and Abdulahad, \{W. H.\} and Huitema, \{M. G.\} and A. Visser and Meijer, \{J. M.\} and Burgerhof, \{J. G. M.\} and Kallenberg, \{C. G. M.\} and A. Vissink and Kroese, \{F. G. M.\} and H. Bootsma",

year = "2012",

month = sep,

language = "English",

volume = "18",

pages = "13--13",

journal = "Oral diseases",

issn = "1354-523X",

publisher = "Wiley",

}

TY - JOUR

T1 - Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjogren's syndrome

T2 - data from a placebo-controlled clinical trial

AU - Spijkervet, F. K. L.

AU - Pollard, R. P. E.

AU - Abdulahad, W. H.

AU - Huitema, M. G.

AU - Visser, A.

AU - Meijer, J. M.

AU - Burgerhof, J. G. M.

AU - Kallenberg, C. G. M.

AU - Vissink, A.

AU - Kroese, F. G. M.

AU - Bootsma, H.

PY - 2012/9

Y1 - 2012/9

M3 - Meeting Abstract

SN - 1354-523X

VL - 18

SP - 13

EP - 13

JO - Oral diseases

JF - Oral diseases

ER -